ICYMI: Evkeeza Now FDA-Approved for HoFH
Xanthoma is an easy sign of high cholesterol conditions like HeFH. If you see this, please go to the doctor immediately! Source: Wikipedia

ICYMI: Evkeeza Now FDA-Approved for HoFH

  While there are existing therapies for individuals living with homozygous familial hypercholesterolemia (HoFH), a rare form of high LDL cholesterol, these therapies often fail to control cholesterol levels for…

Continue Reading ICYMI: Evkeeza Now FDA-Approved for HoFH
Positive Results From Clinical Trial for Children with Homozygous Familial Hypercholesterolemia
source: pixabay.com

Positive Results From Clinical Trial for Children with Homozygous Familial Hypercholesterolemia

Regeneron Pharmaceuticals Inc. has just released positive results from their Phase 3 investigation of Evkeeza as a treatment for homozygous familial hypercholesterolemia (HOFH). Specifically, this trial studied the treatment for…

Continue Reading Positive Results From Clinical Trial for Children with Homozygous Familial Hypercholesterolemia
The FDA has Announced Their Approval of Evkeeza for Homozygous Familial Hypercholesterolemia
source: pixabay.com

The FDA has Announced Their Approval of Evkeeza for Homozygous Familial Hypercholesterolemia

The FDA has just announced their approval of Evkeeza as a therapy for those living with homozygous familial hypercholesterolemia. The therapy is owned by Regeneron Pharmaceuticals. It was evaluated with…

Continue Reading The FDA has Announced Their Approval of Evkeeza for Homozygous Familial Hypercholesterolemia
ICYMI: Good Results From Evinacumab for Rare Form of Familial Hypercholesterolemia
source: pixabay.com

ICYMI: Good Results From Evinacumab for Rare Form of Familial Hypercholesterolemia

  A press release issued recently by Regeneron Pharmaceuticals heralded the acceptance of a Biologics License Application by the FDA for Priority Review of its investigational drug, evinacumab. The Priority…

Continue Reading ICYMI: Good Results From Evinacumab for Rare Form of Familial Hypercholesterolemia
BLA for Evinacumab, a Treatment for HoFH, Receives Priority Review Status
source: pixabay.com

BLA for Evinacumab, a Treatment for HoFH, Receives Priority Review Status

  This week, Regeneron Pharmaceuticals announced that their Biologics License Application (BLA) for evanicumab, a treatment for homozygous familial hypercholesterolemia (HoFH), was granted Priority Review status by the FDA. The…

Continue Reading BLA for Evinacumab, a Treatment for HoFH, Receives Priority Review Status

Results From the Longest Familial Hypercholesterolemia Study to be Announced at the ACC 2019 Conference

New Research to be Presented In just a few days the American College of Cardiology will host their 68th Annual Scientific Session (ACC.19). It will be held in New Orleans,…

Continue Reading Results From the Longest Familial Hypercholesterolemia Study to be Announced at the ACC 2019 Conference
Cómo y por qué usted debe recibir dinero para la medicación HFHo
source: pixabay.com

Cómo y por qué usted debe recibir dinero para la medicación HFHo

Si usted o su ser querido está viviendo con hipercolesterolemia familiar homocigota (HFH), que va a estar encantados con esta noticia - y se lo merece, también! La Fundación Defensor…

Continue Reading Cómo y por qué usted debe recibir dinero para la medicación HFHo
Nuevo tratamiento para la HFHo te reta a ponerle un precio a la vida
Pixabay

Nuevo tratamiento para la HFHo te reta a ponerle un precio a la vida

Niveles altos de colesterol, particularmente colesterol de lipoproteínas de baja densidad (LDL-C) es un problema para muchas personas, pero ninguno más que los que tienen la hipercolesterolemia condición heredada genéticamente…

Continue Reading Nuevo tratamiento para la HFHo te reta a ponerle un precio a la vida
5 razones por lo que este nuevo tratamiento para la HFHo te hará saltar de alegría
Pixabay

5 razones por lo que este nuevo tratamiento para la HFHo te hará saltar de alegría

Si usted ha estado sufriendo de colesterol alto con las puntuaciones tristemente lipoproteínas de baja densidad (LDL), aquí hay algunas noticias de última hora que podría salvar su vida! La…

Continue Reading 5 razones por lo que este nuevo tratamiento para la HFHo te hará saltar de alegría
Esto es lo que ocurre cuando un medicamento pocas personas necesitan recauda miles de millones
Lipitor may go down as one of the most successful drugs in history, but not without some unanswered questions. Source: Drugreporter

Esto es lo que ocurre cuando un medicamento pocas personas necesitan recauda miles de millones

Alan Cassels es un investigador de la política de drogas que, en la edición de agosto de la revista Common Ground, escribió acerca de cómo las empresas y los vendedores…

Continue Reading Esto es lo que ocurre cuando un medicamento pocas personas necesitan recauda miles de millones

Está el nuevo fármaco para la HF Inspirado por Star Wars? A quién le importa, funciona

Parado frente a una multitud de gente hablando sobre su HFHo puede ser intimidante. Imagina que esa multitud fuese un panel de doctores y científicos que son parte de la…

Continue Reading Está el nuevo fármaco para la HF Inspirado por Star Wars? A quién le importa, funciona
How and Why You Should Get Big Money for HoFH Medication
The PAF is increasing its efforts to fund co-pays for those suffering from HoFH.

How and Why You Should Get Big Money for HoFH Medication

If you or your loved one is living with homozygous familial hypercholesterolemia (HoFH), you’re going to be thrilled with this news--and you deserve it, too! The Patient Advocate Foundation (PAF) just announced on November 2nd,…

Continue Reading How and Why You Should Get Big Money for HoFH Medication